2024年 国家自然科学基金青年项目（82403602）

2023年 江苏省自然科学基金青年项目（BK20230842）

2023年 附属中大医院临床研究孵化项目青年项目（GSP-LCYJFH21）

2021年 江苏省研究生创新研究资助项目（YBPY2173）

近5年以第一或通讯作者（含共同）发表SCI期刊论文80余篇，影响因子大于10分论文15篇。 

肾癌代表性论文列举如下：

1.Zhang H, Tao T, Ji J, Zhao T, Sun S, Zhang L, Wu J, Chen M, Chen S, Xu B, Mao W. CircPVT1 Promotes Lung Metastasis and Tumor Progression in Renal Cell Carcinoma by Encoding the cP104aa Peptide and Targeting EIF4A3. Adv Sci (Weinh). 2025 Sep 18:e01211. 

2.Mao W, Wu T, Barge S, Zubair M, Sanchez D, Geng J, Bhattacharya A, Chen M. Comparing oncologic outcomes of partial and radical nephrectomy for T2 renal cell carcinoma: a propensity score matching cohort study and an external multicenter validation. World J Urol. 2025 Mar 12;43(1):166. 

3.Mao W, Wang K, Zhang W, Chen S, Xie J, Zheng Z, Li X, Zhang N, Zhang Y, Zhang H, Peng B, Yao X, Che J, Zheng J, Chen M, Li W. Transfection with Plasmid-Encoding lncRNA-SLERCC nanoparticle-mediated delivery suppressed tumor progression in renal cell carcinoma. J Exp Clin Cancer Res. 2022 Aug 19;41(1):252.

4.Mao W, Wang K, Xu B, Zhang H, Sun S, Hu Q, Zhang L, Liu C, Chen S, Wu J, Chen M, Li W, Peng B. ciRS-7 is a prognostic biomarker and potential gene therapy target for renal cell carcinoma. Mol Cancer. 2021 Nov 5;20(1):142. doi: 10.1186/s12943-021-01443-2. Erratum in: Mol Cancer. 2021 Dec 1;20(1):155. 

5.Mao W, Wang K, Zhang H, Lu H, Sun S, Tian C, Wu Z, Wu J, Xu B, Xu H, Peng B, Chen M. Sarcopenia as a poor prognostic indicator for renal cell carcinoma patients undergoing nephrectomy in China: A multicenter study. Clin Transl Med. 2021 Jan;11(1):e270. 

膀胱良恶性疾病代表性论文列举如下：

1.Mao W, Zhang T, Chen H, Barge S, Wang Z, Olumi A, Alper S, Yu W. Expression and distribution of activin-follistatin-inhibin axis in the urinary bladder. Front Mol Biosci. 2025 Mar 12;12:1519977. 

2.Mao W, Xu K, Wang K, Zhang H, Ji J, Geng J, Sun S, Gu C, Bhattacharya A, Fang C, Tao T, Chen M, Wu J, Chen S, Sun C, Xu B. Single-cell RNA sequencing and spatial transcriptomics of bladder Ewing sarcoma. iScience. 2024 Sep 11;27(10):110921. 

3.Xie J, Zhang H, Wang K, Ni J, Ma X, Khoury CJ, Prifti V, Hoard B, Cerenzia EG, Yin L, Zhang H, Wang R, Zhuo D, Mao W, Peng B. M6A-mediated-upregulation of lncRNA BLACAT3 promotes bladder cancer angiogenesis and hematogenous metastasis through YBX3 nuclear shuttling and enhancing NCF2 transcription. Oncogene. 2023 Sep;42(40):2956-2970. 

4.Mao W, Ma B, Wang K, Wu J, Xu B, Geng J, Zhang H, Chen M. Sarcopenia predicts prognosis of bladder cancer patients after radical cystectomy: A study based on the Chinese population. Clin Transl Med. 2020 Jun;10(2):e105. 

5.Mao W, Huang X, Wang L, Zhang Z, Liu M, Li Y, Luo M, Yao X, Fan J, Geng J. Circular RNA hsa_circ_0068871 regulates FGFR3 expression and activates STAT3 by targeting miR-181a-5p to promote bladder cancer progression. J Exp Clin Cancer Res. 2019 Apr 18;38(1):169.